XNAS 14 Jul, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| David Keefer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2025 | 2,362 | 2,362 | - | - | Stock Option (right to buy) | |
| Angela Walsh | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2025 | 12,075 | 12,075 | - | - | Stock Option (right to buy) | |
| Ralph Grosswald | SVP OF OPERATIONS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2025 | 12,075 | 12,075 | - | - | Stock Option (right to buy) | |
| Gregory Duncan | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2025 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Richard J. Whitley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2025 | 2,362 | 2,362 | - | - | Stock Option (right to buy) | |
| Abel De La Rosa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2025 | 2,362 | 2,362 | - | - | Stock Option (right to buy) | |
| Roger Michael Gendreau | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2025 | 12,075 | 12,075 | - | - | Stock Option (right to buy) | |
| John C. Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2025 | 2,362 | 2,362 | - | - | Stock Option (right to buy) | |
| David Keefer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 210 | 210 | - | - | Stock Option (right to buy) | |
| John C. Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 210 | 210 | - | - | Stock Option (right to buy) | |
| John C. Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 210 | 420 | - | - | Stock Option (right to buy) | |
| Abel De La Rosa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 210 | 210 | - | - | Stock Option (right to buy) | |
| Abel De La Rosa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 210 | 420 | - | - | Stock Option (right to buy) | |
| Richard J. Whitley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 210 | 210 | - | - | Stock Option (right to buy) | |
| Richard J. Whitley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 210 | 420 | - | - | Stock Option (right to buy) | |
| David Keefer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 210 | 420 | - | - | Stock Option (right to buy) | |
| Roger Michael Gendreau | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2024 | 88,085 | 88,085 | - | - | Stock Option (right to buy) | |
| Gregory Duncan | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2024 | 138,835 | 138,835 | - | - | Stock Option (right to buy) | |
| De La Rosa Abel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2024 | 3,959 | 3,959 | - | - | Stock Option (right to buy) | |
| Walsh Angela | SVP OF FINANCE | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2024 | 63,618 | 63,618 | - | - | Stock Option (right to buy) | |
| Thomas John C. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2024 | 4,167 | 4,167 | - | - | Stock Option (right to buy) | |
| Ralph Grosswald | SVP OF OPERATIONS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2024 | 62,568 | 62,568 | - | - | Stock Option (right to buy) | |
| William L. Pridgen | Director | 26 Feb 2024 | 2,917 | 2,917 | - | - | Stock Option (right to buy) | ||
| David Keefer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2024 | 4,709 | 4,709 | - | - | Stock Option (right to buy) | |
| Richard Burch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2024 | 2,917 | 2,917 | - | - | Stock Option (right to buy) | |
| J. Richard Whitley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2024 | 4,000 | 4,000 | - | - | Stock Option (right to buy) | |
| William L. Pridgen | Director | 21 Aug 2023 | 15,335 | 52,045 | - | 1.3 | 19,992 | Common Stock | |
| Gregory Duncan | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 1.25 per share. | 17 Aug 2023 | 25,000 | 57,461 | - | 1.2 | 31,245 | Common Stock |
| David Keefer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 5,250 | 5,250 | - | - | Stock Option (right to buy) | |
| Richard Burch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 5,250 | 5,250 | - | - | Stock Option (right to buy) | |
| Richard J. Whitley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 5,250 | 5,250 | - | - | Stock Option (right to buy) | |
| John C. Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 5,250 | 5,250 | - | - | Stock Option (right to buy) | |
| William L. Pridgen | Director | 15 Jun 2023 | 5,250 | 5,250 | - | - | Stock Option (right to buy) | ||
| Abel De La Rosa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 5,250 | 5,250 | - | - | Stock Option (right to buy) | |
| Roger Michael Gendreau | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2022 | 80,000 | 80,000 | - | - | Stock Option (right to buy) | |
| Greg Duncan | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2022 | 410,000 | 410,000 | - | - | Stock Option (right to buy) | |
| Ralph Grosswald | SVP OF OPERATIONS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2022 | 80,000 | 80,000 | - | - | Stock Option (right to buy) | |
| Angela Walsh | SVP OF FINANCE | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2022 | 80,000 | 80,000 | - | - | Stock Option (right to buy) | |
| Richard J. Whitley | Director | Sale of securities on an exchange or to another person at price $ 0.26 per share. | 08 Dec 2022 | 1,800 | 700 | - | 0.3 | 466 | Common Stock |
| Abel De La Rosa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 5,250 | 5,250 | - | - | Stock Option (right to buy) | |
| William L. Pridgen | Director | 23 Jun 2022 | 5,250 | 5,250 | - | - | Stock Option (right to buy) | ||
| David Keefer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 5,250 | 5,250 | - | - | Stock Option (right to buy) | |
| Angela Walsh | SVP OF FINANCE | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Ralph Grosswald | SVP OF OPERATIONS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Richard Burch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 5,250 | 5,250 | - | - | Stock Option (right to buy) | |
| Greg Duncan | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 90,000 | 90,000 | - | - | Stock Option (right to buy) | |
| Richard J. Whitley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 5,250 | 5,250 | - | - | Stock Option (right to buy) | |
| Roger Michael Gendreau | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| John C. Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 5,250 | 5,250 | - | - | Stock Option (right to buy) | |
| Greg Duncan | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 4.52 per share. | 23 May 2022 | 7,500 | 32,461 | - | 4.5 | 33,900 | Common Stock |
| Angela Walsh | SVP OF FINANCE | Purchase of securities on an exchange or from another person at price $ 4.58 per share. | 23 May 2022 | 2,000 | 3,000 | - | 4.6 | 9,150 | Common Stock |
| William L. Pridgen | Director | 18 May 2022 | 241 | 36,710 | - | 4.5 | 1,085 | Common Stock | |
| Richard J. Whitley | Director | Purchase of securities on an exchange or from another person at price $ 4.53 per share. | 18 May 2022 | 500 | 2,500 | - | 4.5 | 2,263 | Common Stock |
| William L. Pridgen | Director | 17 May 2022 | 13,450 | 36,469 | - | 4.4 | 58,914 | Common Stock | |
| William L. Pridgen | Director | 29 Mar 2022 | 600 | 23,019 | - | 4.9 | 2,964 | Common Stock | |
| William L. Pridgen | Director | 23 Mar 2022 | 2,197 | 22,419 | - | 5.5 | 12,002 | Common Stock | |
| William L. Pridgen | Director | 27 Jan 2022 | 4,180 | 18,722 | - | 6.0 | 24,998 | Common Stock | |
| Abel De La Rosa | Director | Purchase of securities on an exchange or from another person at price $ 5.90 per share. | 07 Jan 2022 | 4,000 | 4,000 | - | 5.9 | 23,584 | Common Stock |
| Richard J. Whitley | Director | Purchase of securities on an exchange or from another person at price $ 5.72 per share. | 06 Jan 2022 | 1,800 | 2,000 | - | 5.7 | 10,296 | Common Stock |
| John C. Thomas | Director | Purchase of securities on an exchange or from another person at price $ 5.65 per share. | 04 Jan 2022 | 1,000 | 1,000 | - | 5.7 | 5,650 | Common Stock |
| David Keefer | Director | Purchase of securities on an exchange or from another person at price $ 5.80 per share. | 04 Jan 2022 | 5,000 | 5,000 | - | 5.8 | 28,975 | Common Stock |
| William L. Pridgen | Director | 03 Jan 2022 | 2,215 | 14,542 | - | 5.4 | 12,034 | Common Stock | |
| Richard J. Whitley | Director | Purchase of securities on an exchange or from another person at price $ 5.72 per share. | 23 Dec 2021 | 200 | 200 | - | 5.7 | 1,145 | Common Stock |
| William L. Pridgen | Director | 21 Dec 2021 | 8,827 | 12,327 | - | 5.7 | 49,997 | Common Stock | |
| Greg Duncan | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 5.52 per share. | 21 Dec 2021 | 5,000 | 24,961 | - | 5.5 | 27,615 | Common Stock |
| William L. Pridgen | Director | 07 Jul 2021 | 942 | 710,734 | - | 6.3 | 5,951 | Common Stock | |
| John C. Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2021 | 7,875 | 7,875 | - | - | Stock Option (right to buy) | |
| Abel De La Rosa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2021 | 7,875 | 7,875 | - | - | Stock Option (right to buy) | |
| Richard J. Whitley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2021 | 7,875 | 7,875 | - | - | Stock Option (right to buy) | |
| Richard Burch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2021 | 7,875 | 7,875 | - | - | Stock Option (right to buy) | |
| David Keefer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2021 | 7,875 | 7,875 | - | - | Stock Option (right to buy) | |
| William L. Pridgen | Director | 22 Jun 2021 | 7,875 | 7,875 | - | - | Stock Option (right to buy) | ||
| Greg Duncan | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2021 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| Ralph Grosswald | VICE PRESIDENT OF OPERATIONS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2021 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Angela Walsh | SVP OF FINANCE | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2021 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Greg Duncan | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 6.36 per share. | 06 Apr 2021 | 382 | 19,961 | - | 6.4 | 2,429 | Common Stock |
| Greg Duncan | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 6.17 per share. | 05 Apr 2021 | 15,675 | 19,579 | - | 6.2 | 96,757 | Common Stock |
| William L. Pridgen | Director | 28 Jan 2021 | 801 | 0 | - | - | Warrant to Purchase Common Stock | ||
| Angela Walsh | VP of Finance | Purchase of securities on an exchange or from another person at price $ 7.30 per share. | 28 Jan 2021 | 1,000 | 1,000 | - | 7.3 | 7,300 | Common Stock |
| David Keefer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jan 2021 | 1,602 | 0 | - | - | Warrant to Purchase Common Stock | |
| David Keefer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.80 per share. | 28 Jan 2021 | 1,602 | 7,808 | - | 7.8 | 12,496 | Common Stock |
| William L. Pridgen | Director | 28 Jan 2021 | 3,500 | 3,500 | - | 7.5 | 26,145 | Common Stock | |
| William L. Pridgen | Director | 28 Jan 2021 | 801 | 727,993 | - | 7.8 | 6,248 | Common Stock | |
| Greg Duncan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2021 | 21,796 | 435,921 | - | - | Stock Option (right to buy) | |
| Ralph Grosswald | VP of Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2021 | 209 | 41,621 | - | - | Stock Option (right to buy) | |
| Angela Walsh | VP of Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2021 | 209 | 41,621 | - | - | Stock Option (right to buy) | |
| Greg Duncan | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2021 | 801 | 0 | - | - | Warrant to Purchase Common Stock | |
| Greg Duncan | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.80 per share. | 06 Jan 2021 | 801 | 3,904 | - | 7.8 | 6,248 | Common Stock |
| Roger Michael Gendreau | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2021 | 41,734 | 41,734 | - | - | Stock Option (right to buy) | |
| Greg Duncan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2020 | 414,125 | 414,125 | - | - | Stock Option (right to buy) | |
| Angela Walsh | VP of Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2020 | 41,412 | 41,412 | - | - | Stock Option (right to buy) | |
| Ralph Grosswald | Vice President of Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2020 | 41,412 | 41,412 | - | - | Stock Option (right to buy) | |
| William L. Pridgen | Director | 17 Dec 2020 | 1,500 | 727,192 | - | 12.0 | 17,970 | Common Stock |